Elevating microglia TREM2 reduces amyloid seeding and suppresses disease-associated microglia
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
TREM2 is exclusively expressed by microglia in the brain and is strongly linked to the risk for Alzheimer’s disease (AD). As microglial responses modulated by TREM2 are central to AD pathogenesis, enhancing TREM2 signaling has been explored as an AD therapeutic strategy. However, the effective therapeutic window targeting TREM2 is unclear. Here, by using microglia-specific inducible mouse models overexpressing human wild-type TREM2 (TREM2-WT) or R47H risk variant (TREM2-R47H), we show that TREM2-WT expression reduces amyloid deposition and neuritic dystrophy only during the early amyloid seeding stage, whereas TREM2-R47H exacerbates amyloid burden during the middle amyloid rapid growth stage. Single-cell RNA sequencing reveals suppressed disease-associated microglia (DAM) signature and reduced DAM population upon TREM2-WT expression in the early stage, whereas upregulated antigen presentation pathway is detected with TREM2-R47H expression in the middle stage. Together, our findings highlight the dynamic effects of TREM2 in modulating AD pathogenesis and emphasize the beneficial effect of enhancing TREM2 function in the early stage of AD development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Hafemeister, C., & Satija, R. (2019) · Genome Biology · doi:10.1186/s13059-019-1874-1 · Cited by 4,479 · cited 1×
“…of selected marker genes in each cluster was visualized with the VlnPlot function from the Seurat package using the normalized and scaled data from SCT transformation, which removes the confounding effect of the gene detection rate and mitochondria mapping percentage (Hafemeister and Satija, 2019).”
MethodOakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 1×
“2 A; Oakley et al., 2006).”
The neuropathological diagnosis of Alzheimer's disease
DeTure, M. A., & Dickson, D. W. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0333-5 · Cited by 3,329 · cited 2×
“Introduction Alzheimer’s disease (AD) is the most common form of dementia defined by the pathological deposition of amyloid-β (Aβ) plaques and neurofibrillary tangles containing hyperphosphorylated tau (DeTure and Dickson, 2019; Hardy and Selkoe, 2002).”
BackgroundFinak, G., McDavid, A., Yajima, M., Deng, J., Gersuk, V., Shalek, A. K., Slichter, C. K., Miller, H. W., McElrath, M. J., Prlic, M., et al. (2015) · Genome Biology · doi:10.1186/s13059-015-0844-5 · Cited by 3,159 · cited 1×
“…in each pairwise comparison within cell clusters (TREM2-WT– induced versus Ctrl or TREM2-R47H–induced versus Ctrl) were calculated using the MAST model while correcting for sex, cellular detection rate, mitochondrial gene percentage, ribosomal gene percentage, and batch (Finak et al., 2015).”
MethodTREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Krasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.008 · Cited by 2,979 · cited 6×
“The microglia cell clusters were further classified into HM, DAM, IRM, REM, MHCII+, and CPM based on the expression patterns of marker genes (Keren-Shaul et al., 2017; Krasemann et al., 2017; Sala Frigerio et al., 2019).”
BackgroundInfluentialSelf-citationMicroglia promote learning-dependent synapse formation through brain-derived neurotrophic factor
Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R., Lafaille, J. J., Hempstead, B. L., Littman, D. R., & Gan, W.-B. (2013) · Cell · doi:10.1016/j.cell.2013.11.030 · Cited by 2,599
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · cited 1×
“TREM2 variant p.R47H has been linked to an increased risk of AD (Guerreiro et al., 2013; Jonsson et al., 2013) with an effect size comparable to that of the APOE4 gene allele, the strongest genetic risk factor for AD (Corder et al., 1993).”
BackgroundDecreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078
Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration
Deczkowska, A., Keren-Shaul, H., Weiner, A., Colonna, M., Schwartz, M., & Amit, I. (2018) · Cell · doi:10.1016/j.cell.2018.05.003 · Cited by 1,474 · cited 2×
“microglia activation from homeostatic to disease-associated state (Deczkowska et al., 2018).”
BackgroundTREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease
Ulland, T. K., Song, W. M., Huang, S. C.-C., Ulrich, J. D., Sergushichev, A., Beatty, W. L., Loboda, A. A., Zhou, Y., Cairns, N. J., Kambal, A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.023 · Cited by 1,263 · cited 1×
“Engagement of TREM2 by ligands initiates signaling through its adaptor DAP12 or DAP10 (Xing et al., 2015) to trigger downstream signaling pathways (Konishi and Kiyama, 2018; Ulland et al., 2017).”
BackgroundRapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease
Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D. M., Bacskai, B. J., & Hyman, B. T. (2008) · Nature · doi:10.1038/nature06616 · Cited by 987 · cited 1×
“Microglial TREM2-GFP expression was induced at birth, and the amyloid plaque was labeled by Methoxy-X04 via intraperitoneal injection prior to imaging (Meyer-Luehmann et al., 2008).”
MethodAlvarez, M. J., Shen, Y., Giorgi, F. M., Lachmann, A., Ding, B. B., Ye, B. H., & Califano, A. (2016) · Nature Genetics · doi:10.1038/ng.3593 · Cited by 966 · cited 2×
“Regulator activity inference The VIPER algorithm has proven to be a useful tool for estimating regulator activity from gene expression data using enriched regulon analysis (Alvarez et al., 2016).”
MethodYeh, F. L., Wang, Y., Tom, I., Gonzalez, L. C., & Sheng, M. (2016) · Neuron · doi:10.1016/j.neuron.2016.06.015 · Cited by 943 · cited 1×
“…interacts with a wide array of ligands such as anionic lipids (Wang et al., 2015), high-density and low-density lipoproteins (Song et al., 2017; Yeh et al., 2016), apoptotic cells (Hsieh et al., 2009), APOE (Atagi et al., 2015; Bailey et al., 2015), and Aβ (Zhao et al., 2018; Zhong et al.,…”
BackgroundRelationship of microglia and astrocytes to amyloid deposits of Alzheimer disease
Itagaki, S., McGeer, P. L., Akiyama, H., Zhu, S., & Selkoe, D. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90115-x · Cited by 940
Differential abundance testing on single-cell data using k-nearest neighbor graphs
Dann, E., Henderson, N. C., Teichmann, S. A., Morgan, M. D., & Marioni, J. C. (2022) · Nature Biotechnology · doi:10.1038/s41587-021-01033-z · Cited by 938 · cited 1×
“Differential abundance was performed using the miloR package (version 0.1.0; Dann et al., 2022), using a k value of 100 and the first seven principal components of the combined PCA space, as determined using the elbow plot of the first 30 principal components.”
MethodInfluentialSala Frigerio, C., Wolfs, L., Fattorelli, N., Thrupp, N., Voytyuk, I., Schmidt, I., Mancuso, R., Chen, W.-T., Woodbury, M. E., Srivastava, G., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.099 · Cited by 926 · cited 8×
“Zhao et al. Journal of Experimental Medicine 8 of 23 Elevating microglia TREM2 reduces amyloid seeding https://doi.org/10.1084/jem.20212479 (HM1-5; clusters 0, 3, 4, 5, and 15; high expression of P2ry12, Csf1r, Cx3cr1, and Tmem119); DAM (cluster 11, high expression of DAM genes identified by Keren-Shaul et al. [2017]…”
BackgroundInfluentialTREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
Wang, Y., Ulland, T. K., Ulrich, J. D., Song, W., Tzaferis, J. A., Hole, J. T., Yuan, P., Mahan, T. E., Shi, Y., Gilfillan, S., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151948 · Cited by 840 · cited 1×
“Unfortunately, the effects of Trem2 deficiency on amyloid load have yielded inconsistent results (Jay et al., 2017; Jay et al., 2015; Parhizkar et al., 2019; Ulrich et al., 2017; Wang et al., 2015; Wang et al., 2016).”
ResultYuan, P., Condello, C., Keene, C. D., Wang, Y., Bird, T. D., Paul, S. M., Luo, W., Colonna, M., Baddeley, D., & Grutzendler, J. (2016) · Neuron · doi:10.1016/j.neuron.2016.05.003 · Cited by 817
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
Kleinberger, G., Yamanishi, Y., Suárez-Calvet, M., Czirr, E., Lohmann, E., Cuyvers, E., Struyfs, H., Pettkus, N., Wenninger-Weinzierl, A., Mazaheri, F., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009093 · Cited by 798 · cited 2×
“Lastly, it was reported that the TREM2-R47H shows reduced shedding to produce sTREM2 (Kleinberger et al., 2014; Song et al., 2018).”
BackgroundResultTREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function
Zhao, Y., Wu, X., Li, X., Jiang, L.-L., Gui, X., Liu, Y., Sun, Y., Zhu, B., Piña-Crespo, J. C., Zhang, M., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.031 · Cited by 763
Self-citationJay, T. R., Miller, C. M., Cheng, P. J., Graham, L. C., Bemiller, S., Broihier, M. L., Xu, G., Margevicius, D., Karlo, J. C., Sousa, G. L., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142322 · Cited by 682 · cited 1×
“Unfortunately, the effects of Trem2 deficiency on amyloid load have yielded inconsistent results (Jay et al., 2017; Jay et al., 2015; Parhizkar et al., 2019; Ulrich et al., 2017; Wang et al., 2015; Wang et al., 2016).”
ResultThe Physiology, Pathology, and Potential Therapeutic Applications of the TREM2 Signaling Pathway
Deczkowska, A., Weiner, A., & Amit, I. (2020) · Cell · doi:10.1016/j.cell.2020.05.003 · Cited by 648
Single-nucleus chromatin accessibility and transcriptomic characterization of Alzheimer’s disease
Morabito, S., Miyoshi, E., Michael, N., Shahin, S., Martini, A. C., Head, E., Silva, J., Leavy, K., Perez-Rosendahl, M., & Swarup, V. (2021) · Nature Genetics · doi:10.1038/s41588-021-00894-z · Cited by 643
Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
Atagi, Y., Liu, C.-C., Painter, M. M., Chen, X.-F., Verbeeck, C., Zheng, H., Li, X., Rademakers, R., Kang, S. S., Xu, H., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.679043 · Cited by 587 · cited 8×
“…interacts with a wide array of ligands such as anionic lipids (Wang et al., 2015), high-density and low-density lipoproteins (Song et al., 2017; Yeh et al., 2016), apoptotic cells (Hsieh et al., 2009), APOE (Atagi et al., 2015; Bailey et al., 2015), and Aβ (Zhao et al., 2018; Zhong et al., 2018).”
BackgroundInfluentialSelf-citationLoss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE
Parhizkar, S., Arzberger, T., Brendel, M., Kleinberger, G., Deussing, M., Focke, C., Nuscher, B., Xiong, M., Ghasemigharagoz, A., Katzmarski, N., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0296-9 · Cited by 555 · cited 4×
“These results are consistent with the previous finding that TREM2 has a limited role in the late or advanced stage of amyloid development in AD (Parhizkar et al., 2019).”
BackgroundResultInfluentialWang, S., Mustafa, M., Yuede, C. M., Salazar, S. V., Kong, P., Long, H., Ward, M., Siddiqui, O., Paul, R., Gilfillan, S., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20200785 · Cited by 549
Leyns, C. E. G., Ulrich, J. D., Finn, M. B., Stewart, F. R., Koscal, L. J., Remolina Serrano, J., Robinson, G. O., Anderson, E., Colonna, M., & Holtzman, D. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710311114 · Cited by 517 · cited 1×
“…studies on TREM2 function in AD using Trem2-knockout mice have generated inconsistent findings of either reducing or enhancing amyloid or tau pathologies (Bemiller et al., 2017; Fitz et al., 2020; Jay et al., 2017; Lee et al., 2021; Leyns et al., 2017; Parhizkar et al., 2019; Yuan et al., 2016).”
BackgroundA role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia
Hsieh, C. L., Koike, M., Spusta, S. C., Niemi, E. C., Yenari, M., Nakamura, M. C., & Seaman, W. E. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06042.x · Cited by 475
Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease
Jay, T. R., Hirsch, A. M., Broihier, M. L., Miller, C. M., Neilson, L. E., Ransohoff, R. M., Lamb, B. T., & Landreth, G. E. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2110-16.2016 · Cited by 457
ApoE4 Accelerates Early Seeding of Amyloid Pathology
Liu, C.-C., Zhao, N., Fu, Y., Wang, N., Linares, C., Tsai, C.-W., & Bu, G. (2017) · Neuron · doi:10.1016/j.neuron.2017.11.013 · Cited by 451 · cited 4×
“To address this, we performed in vivomicrodialysis to analyze the elimination kinetics of Aβ42 in the interstitial fluid (ISF) using our 5xFAD/TREM2mice induced during the early Aβ seeding stage (Liu et al., 2017).”
MethodInfluentialSelf-citationMarsh, S. E., Walker, A. J., Kamath, T., Dissing-Olesen, L., Hammond, T. R., de Soysa, T. Y., Young, A. M. H., Murphy, S., Abdulraouf, A., Nadaf, N., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01022-8 · Cited by 431 · cited 2×
“7 D), which are recently shown to be the markers of ex vivo microglia activation (Marsh et al., 2022).”
BackgroundMarsh, S. E., Kamath, T., Walker, A. J., Dissing-Olesen, L., Hammond, T. R., Young, A. M. H., Abdulraouf, A., Nadaf, N., Dufort, C., Murphy, S., et al. (2020) · doi:10.1101/2020.12.03.408542 · Cited by 430
Lee, C. Y. D., Daggett, A., Gu, X., Jiang, L.-L., Langfelder, P., Li, X., Wang, N., Zhao, Y., Park, C. S., Cooper, Y., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.02.002 · Cited by 396 · cited 5×
“However, Lee et al. (2018) also reported several other upregulated neurodegenerative disease–related genes by TREM2 overexpression (such as (C), and blue and brown modules from cluster 3 (D) are shown.”
BackgroundResultInfluentialZhong, L., Xu, Y., Zhuo, R., Wang, T., Wang, K., Huang, R., Wang, D., Gao, Y., Zhu, Y., Sheng, X., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09118-9 · Cited by 371 · cited 1×
“As sTREM2 is linked to a protective effect against cognitive decline (Ewers et al., 2019) and AD-related pathology and behavior (Zhong et al., 2019), the reduced sTREM2 levels associated with TREM2-R47H in our mouse models may also potentially contribute to the overall increased amyloid pathology.”
BackgroundSelf-citationTranscriptional signature in microglia associated with Aβ plaque phagocytosis
Grubman, A., Choo, X. Y., Chew, G., Ouyang, J. F., Sun, G., Croft, N. P., Rossello, F. J., Simmons, R., Buckberry, S., Landin, D. V., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23111-1 · Cited by 357
TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury
Mazaheri, F., Snaidero, N., Kleinberger, G., Madore, C., Daria, A., Werner, G., Krasemann, S., Capell, A., Trümbach, D., Wurst, W., et al. (2017) · The EMBO Reports · doi:10.15252/embr.201743922 · Cited by 351 · cited 1×
“Zhao et al. Journal of Experimental Medicine 6 of 23 Elevating microglia TREM2 reduces amyloid seeding https://doi.org/10.1084/jem.20212479 It has been reported that in amyloid mouse models, Trem2 deficiency impairs microglia clustering around Aβ plaques (Mazaheri et al., 2017; Wang et al., 2015).”
BackgroundInfluentialEwers, M., Franzmeier, N., Suárez-Calvet, M., Morenas-Rodriguez, E., Caballero, M. A. A., Kleinberger, G., Piccio, L., Cruchaga, C., Deming, Y., Dichgans, M., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav6221 · Cited by 327 · cited 2×
“As sTREM2 is linked to a protective effect against cognitive decline (Ewers et al., 2019) and AD-related pathology and behavior (Zhong et al.”
BackgroundElucidating the Role of TREM2 in Alzheimer’s Disease
Ulrich, J. D., Ulland, T. K., Colonna, M., & Holtzman, D. M. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.042 · Cited by 325
Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region
Schlepckow, K., Monroe, K. M., Kleinberger, G., Cantuti‐Castelvetri, L., Parhizkar, S., Xia, D., Willem, M., Werner, G., Pettkus, N., Brunner, B., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911227 · Cited by 324 · cited 1×
“On the other hand, elevating TREM2 levels (Lee et al., 2018) or signaling (Schlepckow et al., 2020; Wang et al., 2020) may ameliorate amyloid pathogenesis, but the impacts seem to be affected by the age of the animals.”
BackgroundHumanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism
Song, W. M., Joshita, S., Zhou, Y., Ulland, T. K., Gilfillan, S., & Colonna, M. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171529 · Cited by 305
The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E
Bailey, C. C., DeVaux, L. B., & Farzan, M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.677286 · Cited by 303 · cited 8×
“…interacts with a wide array of ligands such as anionic lipids (Wang et al., 2015), high-density and low-density lipoproteins (Song et al., 2017; Yeh et al., 2016), apoptotic cells (Hsieh et al., 2009), APOE (Atagi et al., 2015; Bailey et al., 2015), and Aβ (Zhao et al., 2018; Zhong et al., 2018).”
BackgroundInfluentialTrem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology
Lee, S.-H., Meilandt, W. J., Xie, L., Gandham, V. D., Ngu, H., Barck, K. H., Rezzonico, M. G., Imperio, J., Lalehzadeh, G., Huntley, M. A., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.02.010 · Cited by 300 · cited 1×
“…studies on TREM2 function in AD using Trem2-knockout mice have generated inconsistent findings of either reducing or enhancing amyloid or tau pathologies (Bemiller et al., 2017; Fitz et al., 2020; Jay et al., 2017; Lee et al., 2021; Leyns et al., 2017; Parhizkar et al., 2019; Yuan et al., 2016).”
BackgroundMicroglial TREM2/DAP12 signaling: a double-edged sword in neural diseases
Konishi, H., & Kiyama, H. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00206 · Cited by 300
Bemiller, S. M., McCray, T. J., Allan, K., Formica, S. V., Xu, G., Wilson, G., Kokiko-Cochran, O. N., Crish, S. D., Lasagna-Reeves, C. A., Ransohoff, R. M., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0216-6 · Cited by 299 · cited 1×
“…studies on TREM2 function in AD using Trem2-knockout mice have generated inconsistent findings of either reducing or enhancing amyloid or tau pathologies (Bemiller et al., 2017; Fitz et al., 2020; Jay et al., 2017; Lee et al., 2021; Leyns et al., 2017; Parhizkar et al., 2019; Yuan et al., 2016).”
BackgroundSong, W., Hooli, B., Mullin, K., Jin, S. C., Cella, M., Ulland, T. K., Wang, Y., Tanzi, R. E., & Colonna, M. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.07.004 · Cited by 297 · cited 1×
“TREM2 interacts with a wide array of ligands such as anionic lipids (Wang et al., 2015), high-density and low-density lipoproteins (Song et al., 2017; Yeh et al., 2016), apoptotic cells (Hsieh et al., 2009), APOE (Atagi et al., 2015; Bailey et al., 2015), and Aβ (Zhao et al., 2018; Zhong et al.,…”
BackgroundApoE facilitates the microglial response to amyloid plaque pathology
Ulrich, J. D., Ulland, T. K., Mahan, T. E., Nyström, S., Nilsson, K. P., Song, W. M., Zhou, Y., Reinartz, M., Choi, S., Jiang, H., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171265 · Cited by 297 · cited 1×
“…Experimental Medicine 17 of 23 Elevating microglia TREM2 reduces amyloid seeding https://doi.org/10.1084/jem.20212479 were permeabilized with 0.25% Triton X-100 in PBS and stained with 10 µM X-34 (Cat# SML1953; Sigma-Aldrich) in 40% ethanol + 0.02 M NaOH in PBS as described (Ulrich et al., 2018).”
MethodInfluentialYuan, P., Condello, C., Keene, C. D., Wang, Y., Bird, T. D., Paul, S. M., Luo, W., Colonna, M., Baddeley, D., & Grutzendler, J. (2016) · Neuron · doi:10.1016/j.neuron.2016.09.016 · Cited by 219
AD-linked R47H- TREM2 mutation induces disease-enhancing microglial states via AKT hyperactivation
Sayed, F. A., Kodama, L., Fan, L., Carling, G. K., Udeochu, J. C., Le, D., Li, Q., Zhou, L., Wong, M. Y., Horowitz, R., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe3947 · Cited by 155 · cited 1×
“…that AD brains from TREM2-R47H carriers have increased expression of inflammatory molecules and enhanced AKT signaling in microglia, suggesting a potential gain-of-toxic function of TREM2R47H, although this needs to be further validated, perhaps in preclinical model systems (Sayed et al., 2021).”
BackgroundSelf-citationShi, Y., Andhey, P. S., Ising, C., Wang, K., Snipes, L. L., Boyer, K., Lawson, S., Yamada, K., Qin, W., Manis, M., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.05.034 · Cited by 135
Isolation of Microglia from Mouse or Human Tissue
Bordt, E. A., Block, C. L., Petrozziello, T., Sadri-Vakili, G., Smith, C. J., Edlow, A. G., & Bilbo, S. D. (2020) · STAR Protocols · doi:10.1016/j.xpro.2020.100035 · Cited by 109
The TREM2-DAP12 signaling pathway in Nasu–Hakola disease: a molecular genetics perspective
Humphrey, M. B., Xing, J., & Titus, A. (2015) · Research and Reports in Biochemistry · doi:10.2147/rrbc.s58057 · Cited by 77
Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice
Fitz, N. F., Wolfe, C. M., Playso, B. E., Biedrzycki, R. J., Lu, Y., Nam, K. N., Lefterov, I., & Koldamova, R. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00394-4 · Cited by 68 · cited 1×
“…studies on TREM2 function in AD using Trem2-knockout mice have generated inconsistent findings of either reducing or enhancing amyloid or tau pathologies (Bemiller et al., 2017; Fitz et al., 2020; Jay et al., 2017; Lee et al., 2021; Leyns et al., 2017; Parhizkar et al., 2019; Yuan et al., 2016).”
BackgroundIsolation and Phenotyping of Adult Mouse Microglial Cells
Grabert, K., & McColl, B. W. (2018) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7837-3_7 · Cited by 48
Grubman, A., Choo, X. Y., Chew, G., Ouyang, J. F., Sun, G., Croft, N. P., Rossello, F. J., Simmons, R., Buckberry, S., Landin, D. V., et al. (2019) · doi:10.1101/639054 · Cited by 7
Cited by
Neuroinflammation in Alzheimer disease
Heneka, M. T., van der Flier, W. M., Jessen, F., Hoozemanns, J., Thal, D. R., Boche, D., Brosseron, F., Teunissen, C., Zetterberg, H., Jacobs, A. H., et al. (2025) · Nature Reviews Immunology · doi:10.1038/s41577-024-01104-7 · Cited by 638
The neuroimmune axis of Alzheimer’s disease
Jorfi, M., Maaser-Hecker, A., & Tanzi, R. E. (2023) · Genome Medicine · doi:10.1186/s13073-023-01155-w · Cited by 292
Zhong, L., Sheng, X., Wang, W., Li, Y., Zhuo, R., Wang, K., Zhang, L., Hu, D.-D., Hong, Y., Chen, L., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.06.016 · Cited by 168
Self-citationMicroglia heterogeneity, modeling and cell-state annotation in development and neurodegeneration
Fumagalli, L., Nazlie Mohebiany, A., Premereur, J., Polanco Miquel, P., Bijnens, B., Van de Walle, P., Fattorelli, N., & Mancuso, R. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01931-4 · Cited by 90
Inflammasome assembly in neurodegenerative diseases
Singh, J., Habean, M. L., & Panicker, N. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.07.009 · Cited by 83
Metadata
- Authors
- Zhao, N., Qiao, W., Li, F., Ren, Y., Zheng, J., Martens, Y. A., Wang, X., Li, L., Liu, C.-C., Chen, K., Zhu, Y., Ikezu, T. C., Li, Z., Meneses, A. D., Jin, Y., Knight, J. A., Chen, Y., Bastea, L., Linares, C., Sonustun, B., Job, L., Smith, M. L., Xie, M., Liu, Y. U., Umpierre, A. D., Haruwaka, K., Quicksall, Z. S., Storz, P., Asmann, Y. W., Wu, L.-J., & Bu, G.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2022-09-15
- Volume
- 219
- Issue
- 12
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W4295903538
- Cited by
- 111
- References
- 56
- FWCI
- 5.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.